Literature DB >> 8264497

Digoxin-itraconazole interaction.

C P Alderman, H P Jersmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8264497     DOI： 10.5694/j.1326-5377.1993.tb141392.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  7 in total

1.  Itraconazole-related amaurosis and vomiting due to digoxin toxicity.

Authors:  L A Cone; R B Himelman; J N Hirschberg; J W Hutcheson
Journal:  West J Med       Date:  1996-11

Review 2.  Systemic antifungal agents. Drug interactions of clinical significance.

Authors:  E Albengres; H Le Louët; J P Tillement
Journal:  Drug Saf       Date:  1998-02       Impact factor: 5.606

Review 3.  Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections.

Authors:  M Haria; H M Bryson; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

Review 4.  Advances in the management of digoxin toxicity in the older patient.

Authors:  S W Borron; C Bismuth; J Muszynski
Journal:  Drugs Aging       Date:  1997-01       Impact factor: 3.923

5.  Voriconazole does not affect the steady-state pharmacokinetics of digoxin.

Authors:  Lynn Purkins; Nolan Wood; Diane Kleinermans; Don Nichols
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

Review 6.  The enzymatic basis of drug-drug interactions with systemic triazole antifungals.

Authors:  Yasmine Nivoix; Dominique Levêque; Raoul Herbrecht; Jean-Claude Koffel; Laurence Beretz; Genevieve Ubeaud-Sequier
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 7.  Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.

Authors:  F Pea; M Furlanut
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 5.577
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.